| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.1 | 0.05 |